BALPHARMA — Bal Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Bal Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	R2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	—	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	74.5	90.8	211	118	92.1
Net Total Accounts Receivable
Net Total Receivables	778	951	1,011	946	1,252
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,846	2,282	2,342	2,349	2,622
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	572	622	648	738	842
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,605	3,132	3,198	3,357	3,755
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,656	2,093	2,031	2,195	2,492
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	2,019	2,494	2,478	2,583	2,933
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	586	638	720	774	822
Total Liabilities & Shareholders' Equity	2,605	3,132	3,198	3,357	3,755
Total Common Shares Outstanding